Roche, Ascletis To Collaborate On Hepatitis C Drug In China
This article was originally published in PharmAsia News
Roche and Ascletis have entered into a collaboration to develop and commercialize Roche's investigational drug danoprevir (RG7227) in China for the treatment of hepatitis C, Roche said in a press release.
You may also be interested in...
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.